The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.
 
Simon Heeke
Employment - Marker Therapeutics (I)
Honoraria - Qiagen
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Saumil Gandhi
Research Funding - AstraZeneca; Bristol-Myers Squibb; Nanobiotix
 
Hai T. Tran
No Relationships to Disclose
 
Vincent K. Lam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Seagen; Takeda; Takeda
Research Funding - BMS (Inst); GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
 
Lauren Averett Byers
Honoraria - Clinical Care Options; UpToDate
Consulting or Advisory Role - Abbvie; Amgen; Arrowhead Pharmaceuticals; AstraZeneca; BeiGene; Chugai Pharma; Daiichi Sankyo; Genentech; Jazz Pharmaceuticals; Merck Sharp & Dohme Corp.; Puma Biotechnology
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jazz Pharmaceuticals (Inst)
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Lilly; Menarini; Onconova Therapeutics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen; NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
Carl Michael Gay
Honoraria - Aptitude Health; OncLive/MJH Life Sciences; Peerview
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; G1 Therapeutics; Jazz Pharmaceuticals; KisoJi Biotechnology; Monte Rosa Therapeutics; Pharmerit
Speakers' Bureau - AstraZeneca; BeiGene
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending related to small cell lung cancer transcriptional subtypes.
Travel, Accommodations, Expenses - Dava Oncology; ESMO
 
Mehmet Altan
Consulting or Advisory Role - AstraZeneca; BMS; GlaxoSmithKline
Speakers' Bureau - Nektar
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Shattuck Labs (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - Hengenix
 
Mara Antonoff
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ArriVent Biopharma; AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Novartis; Sensei Biotherapeutics; Spectrum Pharmaceuticals
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Spectrum Pharmaceuticals
 
Janet Chen Tu
No Relationships to Disclose
 
Michelle Pek
Employment - Lucence Diagnostics
Consulting or Advisory Role - Lucence
 
Jonathan Poh
Employment - Lucence Diagnostics
Consulting or Advisory Role - Lucence
Patents, Royalties, Other Intellectual Property - Patents relating to diagnostics technologies have been filed by Lucence Diagnostics Pte Ltd. (Inst)
 
Kao Chin Ngeow
Employment - Lucence Diagnostics
Patents, Royalties, Other Intellectual Property - Inventorship for patents relating to diagnostics technologies filed by employer.
 
Anne S. Tsao
Consulting or Advisory Role - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Epizyme; Genentech/Roche; HERON; Lilly; Novartis; Takeda
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Merck; Millennium; Polaris; Seagen; Seagen; Takeda
Patents, Royalties, Other Intellectual Property - UptoDate
 
Tina Cascone
Honoraria - Brystol-Myers Squibb; IDEOlogy Health; Mark Foundation for Cancer Research; Medscape; Onclive; Peerview; Roche; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Arrowhead Pharmaceuticals; Bristol Myers Squibb; EMD Serono; Genentech; MedImmune; Merck; Regeneron
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dava Oncology; IASLC; IDEOlogy Health; Parker Institute for Cancer Immunotherapy; Society for Immunotherapy of Cancer
 
Marcelo Vailati Negrao
Consulting or Advisory Role - Genentech; Merck; Mirati Therapeutics; Novartis
Research Funding - Alaunos Therapeutics (Inst); AstraZeneca (Inst); Checkmate Pharmaceuticals (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - Apothecom; Ashfield Healthcare; ZIOPHARM Oncology
 
George R. Blumenschein
Employment - Janssen (I); johnon & Johnson (I)
Stock and Other Ownership Interests - Virogin Biotech
Consulting or Advisory Role - Abbvie; Adicet Bio; Amgen; ARIAD; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Clovis Oncology; CytomX Therapeutics; Daiichi Sankyo, INC; Genentech; Genzyme; Gilead Sciences; Instil Bio; InterVenn Biosciences; Janssen Oncology; Johnson & Johnson (I); Lilly; Maverick Therapeutics; MedImmune; Merck; Novartis; Novartis; Onconova Therapeutics; Regeneron; Roche; Sanofi; Seagen; Tyme; Virogin Biotech; Xcovery
Research Funding - Adaptimmune; Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; CytomX Therapeutics; Daiichi Sankyo INC; Duality Biologics; Exelixis; Genentech; GlaxoSmithKline; Immatics; Immunocore; Incyte; Kite, a Gilead company; Macrogenics; MedImmune; Merck; Mythic Therapeutics; Novartis; Regeneron; Repertoire Immune Medicines; Roche; Tmunity Therapeutics, Inc.; Torque; Verastem; Xcovery
 
John Heymach
Consulting or Advisory Role - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; GlaxoSmithKline; Hengrui Pharmaceutical; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; Nexus Health Systems; Pneuma Respiratory; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Yasir Y Elamin
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Lilly; Sanofi; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics
Research Funding - AstraZeneca; Blueprint Medicines; Elevation Oncology; Forward; Lilly; Precision Therapeutics; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics; Xcovery
Travel, Accommodations, Expenses - Lilly